Carmelo Erio Fiore

Guidelines for the management of osteoporosis and fragility fractures

Ranuccio Nuti, Maria Luisa Brandi, Giovanni Antonio Checchia et al. · Internal and Emergency Medicine · 2018 · 325 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss

Agostino Gaudio, Pietra Pennisi, Cornelia Bratengeier et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 314 citations

Medicine, Pathology, Bone Metabolism +16

Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older

Ego Seeman, Bruno Vellas, Claude Laurent Benhamou et al. · Journal of Bone and Mineral Research · 2006 · 201 citations · Full text

Medicine, Geriatric Medicine, Orthopedic Surgery +17

Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus

Agostino Gaudio, Filippo Privitera, Katia Battaglia et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 181 citations · Full text

Medicine, Endocrinology, Bone Grafting +16

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10